Your browser doesn't support javascript.
loading
Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas.
Li, Lili; Xu, Juan; Qiu, Guohua; Ying, Jianming; Du, Zhenfang; Xiang, Tingxiu; Wong, Kai Yau; Srivastava, Gopesh; Zhu, Xiao-Feng; Mok, Tony S; Chan, Anthony Tc; Chan, Francis Kl; Ambinder, Richard F; Tao, Qian.
Afiliação
  • Li L; Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Oncology in South China, Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong.
  • Xu J; Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Oncology in South China, Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong.
  • Qiu G; Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Shenzhen, China.
  • Ying J; Johns Hopkins Singapore, Singapore.
  • Du Z; Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Oncology in South China, Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong.
  • Xiang T; Department of Pathology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Wong KY; Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Oncology in South China, Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong.
  • Srivastava G; Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Zhu XF; Department of Pathology, Queen Mary Hospital, The University of Hong Kong.
  • Mok TS; Department of Pathology, Queen Mary Hospital, The University of Hong Kong.
  • Chan AT; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Chan FK; Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Oncology in South China, Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong.
  • Ambinder RF; Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Oncology in South China, Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong.
  • Tao Q; Institute of Digestive Disease and State Key Laboratory of Digestive Diseases, Department of Medicine and Therapeutics, The Chinese University of Hong Kong.
Theranostics ; 8(1): 61-77, 2018.
Article em En | MEDLINE | ID: mdl-29290793
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Proteína Supressora de Tumor p53 / Regiões Promotoras Genéticas / Fator de Transcrição STAT3 / Epigenômica Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Theranostics Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Hong Kong
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Proteína Supressora de Tumor p53 / Regiões Promotoras Genéticas / Fator de Transcrição STAT3 / Epigenômica Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Theranostics Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Hong Kong